GP33 peptide

This is the H-2Db restricted epitope derived from the lymphocytic choreomeningitis virus (LCMV) glycoprotein gp 33; residues 33 to 41.

Domein: genscript.com Bekijk meer

by Y Liu · 2007 · Cited by 6 — Here we showed that multiple immunizations with LCMV gp33-41 peptide (KAV) in Freund's adjuvant could induce KAV-specific CD8 T cells with low expression of

Domein: pubmed.ncbi.nlm.nih.gov Bekijk meer

LCMV gp33-41, the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and ...

Domein: medchemexpress.com Bekijk meer

LCMV (33–41), GP33 H-2Db restricted epitope derived from the Lymphocytic Choreomeningitis Virus (LCMV) glycoprotein gp 33; residues 33 to 41.

Domein: anaspec.com Bekijk meer

This is the H-2Db restricted epitope derived from the residues 33 to 41 of Lymphocytic Choreomeningitis Virus (LCMV) glycoprotein gp 33.

Domein: eurogentec.com Bekijk meer

KAVYNFATC is a linear peptidic epitope (epitope ID30001) studied as part of Pre-glycoprotein polyprotein GP complex from Lymphocytic choriomeningitis ...

Domein: peptides.de Bekijk meer

by C Stemmer · 1999 · Cited by 38 — We have generated eight reduced peptide bond Ψ(CH 2 –NH) analogues corresponding to the H-2D b -restricted CD8 + T cell epitope (called GP33)

Domein: sciencedirect.com Bekijk meer

by A Bunztman · 2012 · Cited by 20 — These data show that following LCMV infection the CD8 + gp33-specific CD8 T cell response becomes highly restricted with enormous narrowing of the diversity.

Domein: immunityageing.biomedcentral.com Bekijk meer

by MT Puglielli · 2001 · Cited by 77 — However, the GP33-43 peptide can be presented by both H-2Db and H-2Kb MHC class I molecules (11). Whereas the transgenic mice used in the generation of this ...

Domein: pmc.ncbi.nlm.nih.gov Bekijk meer